Studies for Newly Diagnosed Lung Cancer

Studies for Newly Diagnosed Lung Cancer


Photon Therapy Vs. Proton Therapy for Non-small Cell Lung Cancer (RTOG 1308)
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC

Investigator: Ramesh Rengan, MD;   Conditions: Non-small Cell Lung Cancer;    Status: Recruiting;   Study ID: NCT01993810

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

Investigator: Renato G. Martins, MD;   Conditions: Lung Cancer;    Status: Recruiting;   Study ID: NCT02194738

Biomarker-Targeted Second-Line Therapy for Recurrent Stage IIIB-IV Squamous Cell Lung Cancer (SWOG 1400)
S1400 Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer

Investigator: Christina S. Baik, MD;   Conditions: Non-small Cell Lung Cance;    Status: Recruiting;   Study ID: NCT02154490

FLARE RT for Stage IIB-IIIB Non-small Cell Lung Cancer
Personalized Radiation Therapy Through Functional Lung Avoidance and Response-Adaptive Dose Escalation: Utilizing Multimodal Molecular Imaging to Improve the Therapeutic Ratio (FLARE RT)

Investigator: Jing Zeng, MD;   Conditions: Stage IIB Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer, Stage IIIB Non-Small Cell Lung Cancer;    Status: Recruiting;   Study ID: NCT02773238